Until we have adequate notification procedures and adequate patient education about breast density, it’s going to be especially critical for facilities to address all of the above questions to provide their patients with the personalized diagnostic care they need and to offer the opportunity to understand the risks and benefits of early detection through advanced contemporary technologies available.
About the author: Philip Croxford is the president and CEO of Gamma Medica.